Health
U.S. FDA’s Hahn plans ‘significant’ work with AstraZeneca in COVID-19 trial inquiry – Reuters
The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plc’s U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do “very significant work” with the company as it conducts its investigation after an illness in…
By Reuters Staff
FILE PHOTO: A sign at an AstraZeneca site in Macclesfield, Britain, May 19, 2014. REUTERS/Phil Noble/File Photo
(Reuters) – The top U.S. Food and Drug Administration official on Tuesday confirmed AstraZeneca Plcs U.S. COVID-19 vaccine trial is on hold, saying the agency is planning to do very significant work with the company as it conducts its investigation after an illness in a participant in Britain.
Were here to protect the American public and were going to do very signif…
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General17 hours agoAustralian share market set to dive as threat of US recession grows